DELAYED RELEASE CYSTEAMINE IN NEPHROPATHIC CYSTINOSIS PATIENTS AFTER RENAL TRANSPLANT: A SUBGROUP ANALYSIS

被引：0

作者：

Grimm, Paul ^{[1
]}

Langman, Craig ^{[2
]}

Cochat, Pierre ^{[3
]}

Morin, Denis ^{[4
]}

Cornelissen, Elizabeth ^{[5
]}

Deschenes, Georges ^{[6
]}

Elenberg, Ewa ^{[7
]}

Greenbaum, Larry ^{[8
]}

Niaudet, Patrick ^{[9
]}

Checani, Gregg ^{[10
]}

机构：

[1] Stanford Univ, Sch Med, Pediat Nephrol, Stanford, CA 94305 USA

[2] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA

[3] Univ Lyon, Pediat, Lyon, France

[4] Univ Montpellier, Pediat, F-34059 Montpellier, France

[5] Radboud Univ Nijmegen, Pediat Nephrol, Nijimegen, Netherlands

[6] Hop Robert Debre, Pediat, F-75019 Paris, France

[7] Baylor Coll Med, Pediat, Houston, TX 77030 USA

[8] Emory Univ, Pediat, Atlanta, GA 30322 USA

[9] Hop Necker Enfants Malad, Pediat Nephrol, Paris, France

[10] Raptor Pharmaceut, Med Affairs, Novato, CA USA

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2016年 / 31卷

关键词：

D O I：

暂无

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

MP691

引用

页码：1569 / 1569

页数：1

共 50 条

[31] EXPERIENCE OF RENAL TRANSPLANTATION IN TWO PATIENTS WITH NEPHROPATHIC CYSTINOSIS IN TAIWAN
Chen, Cheng-Hsu
Wu, Ming-Ju
Cheng, Chi-Hung
Yu, Tong-Min
Chuang, Ya-Wen
Huang, Shih-Ting
Shu, Kuo-Hsiung
PEDIATRIC TRANSPLANTATION, 2011, 15 : 114 - 115
[32] QUANTIFICATION OF DIMETHYLSULFIDE ASSOCIATED WITH CYSTEAMINE BITARTATE-INDUCED HALITOSIS USING BREATH ANALYSIS IN CYSTINOSIS PATIENTS TREATED WITH DELAYED-RELEASE AND IMMEDIATE-RELEASE CYSTEAMINE BITARTRATE
Greenbaum, Larry
Deschenes, Georges
Levtchenko, Elena
Besouw, Martine
Fosser, Cecilia
Confer, Nils
Zheng, Shuo
Checani, Gregg
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
[33] A Randomized Controlled Crossover Trial with Delayed-Release Cysteamine Bitartrate in Nephropathic Cystinosis: Effectiveness on White Blood Cell Cystine Levels and Comparison of Safety
Langman, Craig B.
Greenbaum, Larry A.
Sarwal, Minnie
Grimm, Paul
Niaudet, Patrick
Deschenes, Georges
Cornelissen, Elisabeth
Morin, Denis
Cochat, Pierre
Matossian, Debora
Gaillard, Segolene
Bagger, Mary Jo
Rioux, Patrice
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (07): : 1112 - 1120
[34] IS CYSTEAMINE THERAPY STILL NECESSARY AFTER RENAL TRANSPLANTATION IN CYSTINOSIS?
Scholten, Marieke C. M.
de Jong, Huib
Cornelissen, Elisabeth A. M.
PEDIATRIC TRANSPLANTATION, 2011, 15 : 81 - 81
[35] Swallowing dysfunction in 101 patients with nephropathic cystinosis - Benefit of long-term cysteamine therapy
Sonies, BC
Almajid, P
Kleta, R
Bernardini, I
Gahl, WA
MEDICINE, 2005, 84 (03) : 137 - 146
[36] Novel Mechanisms for Tissue Injury in Nephropathic Cystinosis and Extended Graft Survival in Cystinosis Transplant Patients.
Sansanwal, P.
Li, L.
Ying, L.
Gahl, W.
Sarwal, Minnie
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 576 - 576
[37] CULTURE OF RENAL TUBULAR CELLS FROM THE URINE OF PATIENTS WITH NEPHROPATHIC CYSTINOSIS
RACUSEN, LC
FIVUSH, BA
ANDERSSON, H
GAHL, WA
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1991, 1 (08): : 1028 - 1033
[38] Impact of compliance to oral cysteamine treatment on the costs of Kidney failure in patients with nephropathic cystinosis in the United Kingdom
Lashilola, Seun
Xu, Weiwei
Azimpour, Khashayar
McCarthy, Michael
Carlot, Sara
Game, David
van der Voort, Judith
BMC NEPHROLOGY, 2023, 24 (01)
[39] Impact of compliance to oral cysteamine treatment on the costs of Kidney failure in patients with nephropathic cystinosis in the United Kingdom
Seun Lashilola
Weiwei Xu
Khashayar Azimpour
Michael McCarthy
Sara Carlot
David Game
Judith van der Voort
BMC Nephrology, 24
[40] An Open-Label Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Cysteamine Bitartrate Delayed-release Capsules (RP103), Compared to Cysteamine Bitartrate Capsules, (Cystagon®) in Patients with Nephropathic Cystinosis
Rioux, P.
Barshop, B.
PEDIATRIC NEPHROLOGY, 2010, 25 (10) : 2197 - 2197

← 1 2 3 4 5 →